|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Finch Therapeutics Group, Inc. (FNCH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
47,150,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Finch Therapeutics Group is a clinical-stage microbiome therapeutics company utilizing its Human-First Discovery platform to develop a class of orally administered biological drugs. Co. is developing therapeutics designed to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. Co.'s Human-First Discovery platform uses reverse translation to identify diseases of dysbiosis and to design microbiome therapeutics that address them. Co.'s primary product candidate, CP101, is an orally administered microbiome therapeutic in development for the prevention of recurrent Clostridioides difficile infection.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,010 |
5,010 |
| Total Buy Value |
$0 |
$0 |
$1,353 |
$1,353 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
8,242 |
9,712 |
9,712 |
21,603 |
| Total Sell Value |
$21,246 |
$26,597 |
$26,597 |
$38,460 |
| Total People Sold |
1 |
1 |
1 |
3 |
| Total Sell Transactions |
2 |
3 |
3 |
6 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smisek Jeffrey A |
|
– • – |
2024-03-28 |
4 |
S |
$2.61 |
$4,176 |
I/I |
(1,600) |
6,512 |
|
- |
|
| Smisek Jeffrey A |
|
– • – |
2024-03-28 |
4 |
S |
$2.57 |
$17,070 |
D/D |
(6,642) |
0 |
|
- |
|
| Smisek Jeffrey A |
|
– • – |
2023-11-22 |
4 |
S |
$3.64 |
$5,351 |
D/D |
(1,470) |
6,642 |
|
- |
|
| Graf Susan E |
Director |
– • – |
2023-06-09 |
4 |
B |
$0.27 |
$1,353 |
D/D |
5,010 |
5,010 |
2.31 |
- |
|
| Blaustein Marc |
Chief Operating Officer |
• – – |
2023-02-21 |
4 |
S |
$0.38 |
$1,755 |
D/D |
(4,619) |
27,995 |
|
- |
|
| Blaustein Marc |
Chief Operating Officer |
• – – |
2022-10-21 |
4 |
S |
$1.39 |
$5,054 |
D/D |
(3,636) |
32,614 |
|
- |
|
| Vittiglio Joseph |
Chief Business & Legal Officer |
• – – |
2022-10-21 |
4 |
S |
$1.39 |
$5,054 |
D/D |
(3,636) |
31,364 |
|
- |
|
| Blaustein Marc |
Chief Operating Officer |
• – – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
36,250 |
|
- |
|
| Vittiglio Joseph |
Chief Business & Legal Officer |
• – – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
|
- |
|
| Haft Nicholas |
Director |
– • – |
2021-12-20 |
4 |
B |
$10.18 |
$649,993 |
I/I |
63,850 |
4,056,907 |
2.1 |
- |
|
| Haft Nicholas |
Director |
– • – |
2021-03-23 |
4 |
B |
$17.00 |
$14,999,967 |
I/I |
882,351 |
882,351 |
2.1 |
- |
|
| Haft Nicholas |
Director |
– • – |
2021-03-23 |
4 |
A |
$0.00 |
$0 |
I/I |
3,110,706 |
1,150,481 |
|
- |
|
| Ferrante Domenic J |
Director |
– • – |
2021-03-23 |
4 |
B |
$17.00 |
$1,749,997 |
I/I |
102,941 |
636,195 |
2.1 |
- |
|
| Ferrante Domenic J |
Director |
– • – |
2021-03-23 |
4 |
A |
$0.00 |
$0 |
I/I |
533,254 |
533,254 |
|
- |
|
| Shumway Chris |
Director |
– • • |
2021-03-23 |
4 |
B |
$17.00 |
$12,499,998 |
D/D |
735,294 |
12,641,441 |
3.92 |
- |
|
| Shumway Chris |
Director |
– • • |
2021-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
11,906,147 |
11,906,147 |
|
- |
|
| Smisek Jeffrey A |
Director |
– • – |
2021-03-23 |
4 |
B |
$17.00 |
$1,499,995 |
I/I |
88,235 |
1,694,541 |
2.1 |
- |
|
| Smisek Jeffrey A |
Director |
– • – |
2021-03-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,606,306 |
1,606,306 |
|
- |
|
| Smith Mark Burnham |
Chief Executive OfficerOfficer |
• • – |
2021-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,903,033 |
|
- |
|
| Kassam Zain |
Chief Medical OfficerOfficer |
• – – |
2021-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,330,351 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
